Cross-presentation by dendritic cells (original) (raw)

• Jung, S. et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17, 211–220 (2002). A seminal paper showing that DCs are essential for cross-priming in vivo.
  Article CAS PubMed PubMed Central Google Scholar
• Kovacsovics-Bankowski, M. & Rock, K. L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243–246 (1995).
• Houde, M. et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 425, 402–406 (2003).
  Article CAS PubMed Google Scholar
• Guermonprez, P. et al. ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425, 397–402 (2003).
  Article CAS PubMed Google Scholar
• Burgdorf, S., Scholz, C., Kautz, A., Tampe, R. & Kurts, C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nature Immunol. 9, 558–566 (2008).
  Article CAS Google Scholar
• Firat, E. et al. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J. Immunol. 178, 2241–2248 (2007).
  Article CAS PubMed Google Scholar
• Saveanu, L. et al. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science 325, 213–217 (2009).
  Article CAS PubMed Google Scholar
• Shen, L., Sigal, L. J., Boes, M. & Rock, K. L. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21, 155–165 (2004).
  Article CAS PubMed Google Scholar
• Bertholet, S. et al. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J. Immunol. 177, 3525–3533 (2006).
  Article CAS PubMed Google Scholar
• Merzougui, N., Kratzer, R., Saveanu, L. & van Endert, P. A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen. EMBO Rep. 12, 1257–1264 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Chefalo, P. J., Grandea, A. G., Van Kaer, L. & Harding, C. V. Tapasin−/− and TAP1−/− macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. J. Immunol. 170, 5825–5833 (2003).
  Article CAS PubMed Google Scholar
• Van Kaer, L., Ashton-Rickardt, P. G., Ploegh, H. L. & Tonegawa, S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells. Cell 71, 1205–1214 (1992).
  Article CAS PubMed Google Scholar
• Day, P. M., Esquivel, F., Lukszo, J., Bennink, J. R. & Yewdell, J. W. Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. Immunity 2, 137–147 (1995).
  Article CAS PubMed Google Scholar
• Palmowski, M. J. et al. Role of immunoproteasomes in cross-presentation. J. Immunol. 177, 983–990 (2006).
  Article CAS PubMed Google Scholar
• Lizee, G. et al. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nature Immunol. 4, 1065–1073 (2003).
  Article CAS Google Scholar
• Basha, G. et al. A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nature Immunol. 13, 237–245 (2012).
  Article CAS Google Scholar
• Zou, L. et al. The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells. Proc. Natl Acad. Sci. USA 106, 15801–15806 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Delamarre, L., Pack, M., Chang, H., Mellman, I. & Trombetta, E. S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307, 1630–1634 (2005). This study demonstrates that limited antigen degradation favours antigen presentation in DCs.
  Article CAS PubMed Google Scholar
• Accapezzato, D. et al. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J. Exp. Med. 202, 817–828 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Belizaire, R. & Unanue, E. R. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc. Natl Acad. Sci. USA 106, 17463–17468 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Burgdorf, S., Kautz, A., Bohnert, V., Knolle, P. A. & Kurts, C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316, 612–616 (2007).
  CAS PubMed Google Scholar
• Tacken, P. J. et al. Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation. Blood 118, 4111–4119 (2011).
  Article CAS PubMed Google Scholar
• van Montfoort, N. et al. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc. Natl Acad. Sci. USA 106, 6730–6735 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Savina, A. et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126, 205–218 (2006). This paper demonstrates the connection between pH regulation, antigen degradation and cross-presentation.
  Article CAS PubMed Google Scholar
• Jancic, C. et al. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nature Cell Biol. 9, 367–378 (2007).
  Article CAS PubMed Google Scholar
• Mantegazza, A. R. et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112, 4712–4722 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Rybicka, J. M., Balce, D. R., Khan, M. F., Krohn, R. M. & Yates, R. M. NADPH oxidase activity controls phagosomal proteolysis in macrophages through modulation of the lumenal redox environment of phagosomes. Proc. Natl Acad. Sci. USA 107, 10496–10501 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Rybicka, J. M., Balce, D. R., Chaudhuri, S., Allan, E. R. & Yates, R. M. Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner. EMBO J. 31, 932–944 (2012).
  Article CAS PubMed Google Scholar
• Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. & Amigorena, S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nature Cell Biol. 1, 362–368 (1999).
  Article CAS PubMed Google Scholar
• Ackerman, A. L., Kyritsis, C., Tampe, R. & Cresswell, P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl Acad. Sci. USA 100, 12889–12894 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Gagnon, E. et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119–131 (2002).
  Article CAS PubMed Google Scholar
• Muller-Taubenberger, A. et al. Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis. EMBO J. 20, 6772–6782 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Touret, N. et al. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 123, 157–170 (2005).
  Article CAS PubMed Google Scholar
• Ackerman, A. L., Giodini, A. & Cresswell, P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 25, 607–617 (2006). One of the few papers proposing a molecular mechanism for the translocation of exogenous antigens into the cytosol.
  Article CAS PubMed Google Scholar
• Cebrian, I. et al. Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell 147, 1355–1368 (2011).
  Article CAS PubMed Google Scholar
• Norbury, C. C., Chambers, B. J., Prescott, A. R., Ljunggren, H. G. & Watts, C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27, 280–288 (1997).
  Article CAS PubMed Google Scholar
• Lin, M. L. et al. Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc. Natl Acad. Sci. USA 105, 3029–3034 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zehner, M. et al. Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation. Proc. Natl Acad. Sci. USA 108, 9933–9938 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Segura, E., Albiston, A. L., Wicks, I. P., Chai, S. Y. & Villadangos, J. A. Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc. Natl Acad. Sci. USA 106, 20377–20381 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803–815 (2006).
  Article CAS PubMed Google Scholar
• Giodini, A. & Cresswell, P. Hsp90-mediated cytosolic refolding of exogenous proteins internalized by dendritic cells. EMBO J. 27, 201–211 (2008).
  Article CAS PubMed Google Scholar
• Singh, R. & Cresswell, P. Defective cross-presentation of viral antigens in GILT-free mice. Science 328, 1394–1398 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Imai, T. et al. Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells. Proc. Natl Acad. Sci. USA 108, 16363–16368 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Smith, M. H., Ploegh, H. L. & Weissman, J. S. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science 334, 1086–1090 (2011).
  Article CAS PubMed Google Scholar
• Shortman, K. & Liu, Y. J. Mouse and human dendritic cell subtypes. Nature Rev. Immunol. 2, 151–161 (2002).
  Article CAS Google Scholar
• Vremec, D. et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176, 47–58 (1992).
  Article CAS PubMed Google Scholar
• Poulin, L. F. et al. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204, 3119–3131 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Bursch, L. S. et al. Identification of a novel population of langerin+ dendritic cells. J. Exp. Med. 204, 3147–3156 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ginhoux, F. et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204, 3133–3146 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ginhoux, F. et al. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206, 3115–3130 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Leon, B., Lopez-Bravo, M. & Ardavin, C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26, 519–531 (2007).
  Article CAS PubMed Google Scholar
• Luber, C. A. et al. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32, 279–289 (2010).
  Article CAS PubMed Google Scholar
• Segura, E. et al. Differential expression of pathogen-recognition molecules between dendritic cell subsets revealed by plasma membrane proteomic analysis. Mol. Immunol. 47, 1765–1773 (2010).
  Article CAS PubMed Google Scholar
• Shortman, K. & Heath, W. R. The CD8+ dendritic cell subset. Immunol. Rev. 234, 18–31 (2010).
  Article CAS PubMed Google Scholar
• Kamphorst, A. O., Guermonprez, P., Dudziak, D. & Nussenzweig, M. C. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J. Immunol. 185, 3426–3435 (2010).
  Article CAS PubMed Google Scholar
• den Haan, J. M. & Bevan, M. J. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8+ and CD8− dendritic cells in vivo. J. Exp. Med. 196, 817–827 (2002). This study shows that CD8 − DCs can cross-present certain forms of antigen.
  Article CAS PubMed PubMed Central Google Scholar
• del Rio, M. L., Rodriguez-Barbosa, J. I., Kremmer, E. & Forster, R. CD103− and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol. 178, 6861–6866 (2007).
  Article CAS PubMed Google Scholar
• GeurtsvanKessel, C. H. et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells. J. Exp. Med. 205, 1621–1634 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Beauchamp, N. M., Busick, R. Y. & Alexander-Miller, M. A. Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection. J. Virol. 84, 10191–10199 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Desch, A. N. et al. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 208, 1789–1797 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Bedoui, S. et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nature Immunol. 10, 488–495 (2009).
  Article CAS Google Scholar
• Henri, S. et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207, 189–206 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, L. et al. Langerin expressing cells promote skin immune responses under defined conditions. J. Immunol. 180, 4722–4727 (2008).
  Article CAS PubMed Google Scholar
• Bursch, L. S., Rich, B. E. & Hogquist, K. A. Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens. J. Immunol. 182, 4657–4664 (2009).
  Article CAS PubMed Google Scholar
• Igyarto, B. Z. et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35, 260–272 (2011).
  Article CAS PubMed Google Scholar
• Villadangos, J. A. & Young, L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29, 352–361 (2008).
  Article CAS PubMed Google Scholar
• Mouries, J. et al. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood 112, 3713–3722 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sapoznikov, A. et al. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. J. Exp. Med. 204, 1923–1933 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, H. K. et al. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J. Exp. Med. 206, 359–370 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Le Borgne, M. et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24, 191–201 (2006).
  Article CAS PubMed Google Scholar
• Wakim, L. M., Waithman, J., van Rooijen, N., Heath, W. R. & Carbone, F. R. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 319, 198–202 (2008).
  CAS PubMed Google Scholar
• Aldridge, J. R. Jr et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl Acad. Sci. USA 106, 5306–5311 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ballesteros-Tato, A., Leon, B., Lund, F. E. & Randall, T. D. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenza. Nature Immunol. 11, 216–224 (2010).
• Bedoui, S. et al. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses. J. Immunol. 182, 4200–4207 (2009).
  Article CAS PubMed Google Scholar
• Sathe, P. et al. The acquisition of antigen cross-presentation function by newly formed dendritic cells. J. Immunol. 186, 5184–5192 (2011).
  Article CAS PubMed Google Scholar
• Dzionek, A. et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165, 6037–6046 (2000).
  Article CAS PubMed Google Scholar
• Lindstedt, M., Lundberg, K. & Borrebaeck, C. A. Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J. Immunol. 175, 4839–4846 (2005).
  Article CAS PubMed Google Scholar
• McIlroy, D. et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood 97, 3470–3477 (2001).
  Article CAS PubMed Google Scholar
• Segura, E. et al. Characterization of resident and migratory dendritic cells in human lymph nodes. J. Exp. Med. 209, 653–660 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Klechevsky, E. et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29, 497–510 (2008). This paper shows a functional specialization of human skin DCs, with Langerhans cells being the most efficient for cross-presentation, in contrast to their mouse counterparts.
  Article CAS PubMed PubMed Central Google Scholar
• Haniffa, M. et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J. Exp. Med. 206, 371–385 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bachem, A. et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 207, 1273–1281 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Crozat, K. et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells. J. Exp. Med. 207, 1283–1292 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Jongbloed, S. L. et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207, 1247–1260 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Poulin, L. F. et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells. J. Exp. Med. 207, 1261–1271 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Porgador, A., Yewdell, J. W., Deng, Y., Bennink, J. R. & Germain, R. N. Localization, quantitation, and in situ detection of specific peptide–MHC class I complexes using a monoclonal antibody. Immunity 6, 715–726 (1997).
  Article CAS PubMed Google Scholar
• Iyoda, T. et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195, 1289–1302 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Schulz, O. & Reis e Sousa, C. Cross-presentation of cell-associated antigens by CD8α+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107, 183–189 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Pooley, J. L., Heath, W. R. & Shortman, K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8− dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166, 5327–5330 (2001).
  Article CAS PubMed Google Scholar
• Schnorrer, P. et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl Acad. Sci. USA 103, 10729–10734 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Savina, A. et al. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8+ dendritic cells. Immunity 30, 544–555 (2009).
  Article CAS PubMed Google Scholar
• Dudziak, D. et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107–111 (2007).
  Article CAS PubMed Google Scholar
• Dorner, B. G. et al. Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. Immunity 31, 823–833 (2009).
  Article CAS PubMed Google Scholar
• Edelson, B. T. et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells. J. Exp. Med. 207, 823–836 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Crozat, K. et al. Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type. J. Immunol. 187, 4411–4415 (2011).
  Article CAS PubMed Google Scholar
• Hickman, H. D. et al. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nature Immunol. 9, 155–165 (2008).
  Article CAS Google Scholar
• Xu, R. H., Remakus, S., Ma, X., Roscoe, F. & Sigal, L. J. Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response. PLoS Pathog. 6, e1000768 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• John, B. et al. Dynamic imaging of CD8+ T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathog. 5, e1000505 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wakim, L. M. & Bevan, M. J. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 471, 629–632 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Thery, C., Ostrowski, M. & Segura, E. Membrane vesicles as conveyors of immune responses. Nature Rev. Immunol. 9, 581–593 (2009).
  Article CAS Google Scholar
• Allan, R. S. et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25, 153–162 (2006).
  Article CAS PubMed Google Scholar
• Allan, R. S. et al. Epidermal viral immunity induced by CD8α+ dendritic cells but not by Langerhans cells. Science 301, 1925–1928 (2003).
  Article CAS PubMed Google Scholar
• Eidsmo, L. et al. Differential migration of epidermal and dermal dendritic cells during skin infection. J. Immunol. 182, 3165–3172 (2009).
  Article CAS PubMed Google Scholar
• Belz, G. T. et al. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I- restricted antigen presentation after lung infection with virus. Proc. Natl Acad. Sci. USA 101, 8670–8675 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lukens, M. V., Kruijsen, D., Coenjaerts, F. E., Kimpen, J. L. & van Bleek, G. M. Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J. Virol. 83, 7235–7243 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wilson, N. S. et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nature Immunol. 7, 165–172 (2006).
  Article CAS Google Scholar
• Lundie, R. J. et al. Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8α+ dendritic cells. Proc. Natl Acad. Sci. USA 105, 14509–14514 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Cockburn, I. A. et al. Dendritic cells and hepatocytes use distinct pathways to process protective antigen from Plasmodium in vivo. PLoS Pathog. 7, e1001318 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097–1100 (2008). Using genetically modified mice specifically lacking DCs of the CD8+ lineage, references 94 and 109 show that such DCs are essential in vivo for the initiation of antiviral and antitumour immune responses through cross-priming.
  Article CAS PubMed PubMed Central Google Scholar
• Mashayekhi, M. et al. CD8α+ dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35, 249–259 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Diamond, M. S. et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med. 208, 1989–2003 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Fuertes, M. B. et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells. J. Exp. Med. 208, 2005–2016 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lorenzi, S. et al. Type I IFNs control antigen retention and survival of CD8α+ dendritic cells after uptake of tumor apoptotic cells leading to cross-priming. J. Immunol. 186, 5142–5150 (2011).
  Article CAS PubMed Google Scholar
• Asano, K. et al. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 34, 85–95 (2011).
  Article CAS PubMed Google Scholar
• Bevan, M. J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283–1288 (1976). A seminal paper on the identification of cross-presentation.
  Article CAS PubMed Google Scholar
• Bevan, M. J. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117, 2233–2238 (1976).
  CAS PubMed Google Scholar
• den Haan, J. M., Lehar, S. M. & Bevan, M. J. CD8+ but not CD8− dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192, 1685–1696 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Valujskikh, A., Hartig, C. & Heeger, P. S. Indirectly primed CD8+ T cells are a prominent component of the allogeneic T-cell repertoire after skin graft rejection in mice. Transplantation 71, 418–421 (2001).
  Article CAS PubMed Google Scholar
• He, C. & Heeger, P. S. CD8 T cells can reject major histocompatibility complex class I-deficient skin allografts. Am. J. Transplant. 4, 698–704 (2004).
  Article PubMed Google Scholar
• Celli, S., Albert, M. L. & Bousso, P. Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy. Nature Med. 17, 744–749 (2011). A very elegant study in which the authors analyse the dynamics of allograft rejection by two-photon microscopy.
  Article CAS PubMed Google Scholar
• Valujskikh, A., Lantz, O., Celli, S., Matzinger, P. & Heeger, P. S. Cross-primed CD8+ T cells mediate graft rejection via a distinct effector pathway. Nature Immunol. 3, 844–851 (2002).
  Article CAS Google Scholar
• Kreisel, D. et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nature Med. 8, 233–239 (2002).
  Article CAS PubMed Google Scholar
• Anderson, M. S. et al. Projection of an immunological self shadow within the thymus by the Aire protein. Science 298, 1395–1401 (2002).
  Article CAS PubMed Google Scholar
• Derbinski, J., Schulte, A., Kyewski, B. & Klein, L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nature Immunol. 2, 1032–1039 (2001).
  Article CAS Google Scholar
• Gallegos, A. M. & Bevan, M. J. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 200, 1039–1049 (2004). An interesting study that reveals the cooperation between and relative contributions of DCs and mTECs in the intrathymic deletion of self-reactive T cells.
  Article CAS PubMed PubMed Central Google Scholar
• Gray, D., Abramson, J., Benoist, C. & Mathis, D. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J. Exp. Med. 204, 2521–2528 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Viret, C., Barlow, A. K. & Janeway, C. A. Jr. On the intrathymic intercellular transfer of self-determinants. Immunol. Today 20, 8–10 (1999).
  Article CAS PubMed Google Scholar
• Koble, C. & Kyewski, B. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J. Exp. Med. 206, 1505–1513 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bonasio, R. et al. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nature Immunol. 7, 1092–1100 (2006).
  Article CAS Google Scholar
• Klein, L., Roettinger, B. & Kyewski, B. Sampling of complementing self-antigen pools by thymic stromal cells maximizes the scope of central T cell tolerance. Eur. J. Immunol. 31, 2476–2486 (2001).
  Article CAS PubMed Google Scholar
• Fontenot, J. D. & Rudensky, A. Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nature Immunol. 6, 331–337 (2005).
  Article CAS Google Scholar
• Sakaguchi, S. et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8–27 (2006).
  Article CAS PubMed Google Scholar
• Shevach, E. M. et al. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol. Rev. 212, 60–73 (2006).
  Article CAS PubMed Google Scholar
• Hernandez, J., Aung, S., Redmond, W. L. & Sherman, L. A. Phenotypic and functional analysis of CD8+ T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194, 707–717 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Kurts, C. et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186, 2057–2062 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Kurts, C. et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923–930 (1996).
  Article CAS PubMed Google Scholar
• Belz, G. T. et al. The CD8α+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099–1104 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769–779 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Bonifaz, L. et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196, 1627–1638 (2002). A pioneering study on the targeting of cross-presenting DCs in vivo for immunotherapy.
  Article CAS PubMed PubMed Central Google Scholar
• Dresch, C., Edelmann, S. L., Marconi, P. & Brocker, T. Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo. J. Immunol. 181, 4495–4506 (2008).
  Article CAS PubMed Google Scholar
• Luckashenak, N. et al. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity 28, 521–532 (2008). A study that nicely demonstrates the involvement of DCs in peripheral cross-tolerance to endogenous TSAs in a non-TCR-transgenic model.
  Article CAS PubMed Google Scholar
• Chung, Y., Chang, J. H., Kweon, M. N., Rennert, P. D. & Kang, C. Y. CD8α−11b+ dendritic cells but not CD8α+ dendritic cells mediate cross-tolerance toward intestinal antigens. Blood 106, 201–206 (2005).
  Article CAS PubMed Google Scholar
• Lutz, M. B. & Kurts, C. Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells. Eur. J. Immunol. 39, 2325–2330 (2009).
  Article CAS PubMed Google Scholar
• Lukacs-Kornek, V. et al. The kidney-renal lymph node-system contributes to cross-tolerance against innocuous circulating antigen. J. Immunol. 180, 706–715 (2008).
  Article CAS PubMed Google Scholar
• Jaensson, E. et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J. Exp. Med. 205, 2139–2149 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Cohen, J. N. et al. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J. Exp. Med. 207, 681–688 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Gardner, J. M. et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321, 843–847 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Fletcher, A. L. et al. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J. Exp. Med. 207, 689–697 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Nichols, L. A. et al. Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. J. Immunol. 179, 993–1003 (2007).
  Article CAS PubMed Google Scholar
• Lee, J. W. et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nature Immunol. 8, 181–190 (2007).
  Article CAS Google Scholar
• Fletcher, A. L., Malhotra, D. & Turley, S. J. Lymph node stroma broaden the peripheral tolerance paradigm. Trends Immunol. 32, 12–18 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Vambutas, A. et al. Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model. Vaccine 23, 5271–5280 (2005).
  Article CAS PubMed Google Scholar
• Kantoff, P. W. et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 363, 411–422 (2010).
  Article CAS PubMed Google Scholar
• Melief, C. J. Cancer immunotherapy by dendritic cells. Immunity 29, 372–383 (2008).
  Article CAS PubMed Google Scholar
• Zwaveling, S. et al. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J. Immunol. 169, 350–358 (2002).
  Article CAS PubMed Google Scholar
• Faure, F. et al. Long-lasting cross-presentation of tumor antigen in human DC. Eur. J. Immunol. 39, 380–390 (2009).
  Article CAS PubMed Google Scholar
• Garulli, B., Stillitano, M. G., Barnaba, V. & Castrucci, M. R. Primary CD8+ T-cell response to soluble ovalbumin is improved by chloroquine treatment in vivo. Clin. Vaccine Immunol. 15, 1497–1504 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Belnoue, E. et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172, 2487–2495 (2004).
  Article CAS PubMed Google Scholar
• Roestenberg, M. et al. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 361, 468–477 (2009).
  Article CAS PubMed Google Scholar
• Sauerwein, R. W., Bijker, E. M. & Richie, T. L. Empowering malaria vaccination by drug administration. Curr. Opin. Immunol. 22, 367–373 (2010).
  Article CAS PubMed Google Scholar
• Tacken, P. J., de Vries, I. J., Torensma, R. & Figdor, C. G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nature Rev. Immunol. 7, 790–802 (2007).
  Article CAS Google Scholar
• Tacken, P. J. et al. Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood 118, 6836–6844 (2011).
  Article CAS PubMed Google Scholar
• Herre, J. et al. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104, 4038–4045 (2004).
  Article CAS PubMed Google Scholar
• Bonifaz, L. C. et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815–824 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Caminschi, I. et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112, 3264–3273 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sancho, D. et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J. Clin. Invest. 118, 2098–2110 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Idoyaga, J. et al. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 180, 3647–3650 (2008).
  Article CAS PubMed Google Scholar
• Fayolle, C., Sebo, P., Ladant, D., Ullmann, A. & Leclerc, C. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes. J. Immunol. 156, 4697–4706 (1996).
  CAS PubMed Google Scholar
• Saron, M. F. et al. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. Proc. Natl Acad. Sci. USA 94, 3314–3319 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Srivastava, P. Roles of heat-shock proteins in innate and adaptive immunity. Nature Rev. Immunol. 2, 185–194 (2002).
  Article CAS Google Scholar
• Vingert, B. et al. The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur. J. Immunol. 36, 1124–1135 (2006).
  Article CAS PubMed Google Scholar
• Idoyaga, J. et al. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl Acad. Sci. USA 108, 2384–2389 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Castro, F. V. et al. CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses. Eur. J. Immunol. 38, 2263–2273 (2008).
  Article CAS PubMed Google Scholar
• Kratzer, R., Mauvais, F. X., Burgevin, A., Barilleau, E. & van Endert, P. Fusion proteins for versatile antigen targeting to cell surface receptors reveal differential capacity to prime immune responses. J. Immunol. 184, 6855–6864 (2010).
  Article CAS PubMed Google Scholar
• Huysamen, C., Willment, J. A., Dennehy, K. M. & Brown, G. D. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J. Biol. Chem. 283, 16693–16701 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Joffre, O. P., Sancho, D., Zelenay, S., Keller, A. M. & Reis e Sousa, C. Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A. Eur. J. Immunol. 40, 1255–1265 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Schreibelt, G. et al. The C type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells. Blood 119, 2284–2292 (2012).
  Article CAS PubMed Google Scholar
• Hoeffel, G. et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27, 481–492 (2007).
  Article CAS PubMed Google Scholar
• Mittag, D. et al. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J. Immunol. 186, 6207–6217 (2011).
  Article CAS PubMed Google Scholar
• Sancho, D. et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458, 899–903 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Di Pucchio, T. et al. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nature Immunol. 9, 551–557 (2008).
  Article CAS Google Scholar
• Batchelor, J. R., Welsh, K. I., Maynard, A. & Burgos, H. Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J. Exp. Med. 150, 455–464 (1979).
  Article CAS PubMed Google Scholar
• Lechler, R. I. & Batchelor, J. R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155, 31–41 (1982). References 182 and 183 are pioneering studies demonstrating the importance of passenger leukocytes in acute allograft rejection.
  Article CAS PubMed Google Scholar
• Matzinger, P. & Bevan, M. J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell. Immunol. 29, 1–5 (1977).
  Article CAS PubMed Google Scholar
• Kaye, J. & Janeway, C. A. Jr . The Fab fragment of a directly activating monoclonal antibody that precipitates a disulfide-linked heterodimer from a helper T cell clone blocks activation by either allogeneic Ia or antigen and self-Ia. J. Exp. Med. 159, 1397–1412 (1984).
  Article CAS PubMed Google Scholar
• Smith, P. A., Brunmark, A., Jackson, M. R. & Potter, T. A. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL). J. Exp. Med. 185, 1023–1033 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Jankovic, V., Remus, K., Molano, A. & Nikolich-Zugich, J. T cell recognition of an engineered MHC class I molecule: implications for peptide-independent alloreactivity. J. Immunol. 169, 1887–1892 (2002).
  Article CAS PubMed Google Scholar
• Obst, R., Netuschil, N., Klopfer, K., Stevanovic, S. & Rammensee, H. G. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules. J. Exp. Med. 191, 805–812 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Reiser, J. B. et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nature Immunol. 1, 291–297 (2000).
  Article CAS Google Scholar
• Luz, J. G. et al. Structural comparison of allogeneic and syngeneic T cell receptor–peptide–major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing Vβ interactions. J. Exp. Med. 195, 1175–1186 (2002).
  Article CAS PubMed PubMed Central Google Scholar